Besipirdine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBesipirdine
Drug Alias Namebesipirdina贝西吡啶besipirdinumHP-749P-867493
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsAdrenergic receptors alpha-2 antagonists
TargetsAdrenergic receptors alpha-1Adrenergic receptors alpha-2
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUrogeneSanofi
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG